Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atazanavir powder boosted with ritonavir in pediatric HIV infection
2010-024537-23Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of atazanavir and ritonavir in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Primary endpoints: Number of subjects who died and Serious adverse events and discontinuations due to adverse events through Week 48. Started Apr 2011; status: completed.
02
Drugs
atazanavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2010-024537-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024537-23.